Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi®)

被引:35
|
作者
Kroon, FP [1 ]
van Dissel, JT [1 ]
Ravensbergen, E [1 ]
Nibbering, PH [1 ]
van Furth, R [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Infect Dis C5P, NL-2300 RC Leiden, Netherlands
关键词
HIV-infection; salmonella typhi; polysaccharide salmonella Vi-antigen;
D O I
10.1016/S0264-410X(99)00167-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infections with Salmonella species, including Salmonella typhi, are more frequently observed in HIV-infected individuals than in healthy individuals. HIV-infected individuals were vaccinated with polysaccharide vaccine against Salmonella typhi (Typhim-Vi(R)) which is assumed to be a T-cell-independent antigen. We found that the antibody response in patients with < 200 x 10(6)/l CD4(+) T lymphocytes was significantly lower compared with patients with greater than or equal to 200 x 10(6)/l CD4(+) T lymphocytes and healthy controls. The antibody response after vaccination with the polysaccharide salmonella Vi-antigen was correlated with the number of CD4(+) T lymphocytes and therefore Typhim-Vi can be considered to be a T-cell-independent type 2 antigen. The results of this study indicate that after vaccination the proportion of HIV-infected individuals with protective antibody concentrations against Salmonella typhi will be lower than in healthy controls. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2941 / 2945
页数:5
相关论文
共 50 条
  • [31] ANTIBODY-RESPONSE TO 23-VALENT PNEUMOCOCCAL VACCINE IN HIV-INFECTED CHILDREN
    PETERS, VB
    HODES, DS
    DIAMANT, EP
    CIMINO, CO
    MADORE, DV
    PEDIATRIC RESEARCH, 1994, 35 (04) : A192 - A192
  • [32] Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi
    Belde, Vivek
    Cravens, Matthew P.
    Gulandijany, Dania
    Walker, Justin A.
    Palomo-Caturla, Isabel
    Alugupalli, Akhil S.
    Sandilya, Vijay K.
    Mahmoud, Tamer
    Baumler, Andreas J.
    Kearney, John F.
    Alugupalli, Kishore R.
    INFECTION AND IMMUNITY, 2018, 86 (09)
  • [33] Do HIV-infected persons have an increased risk of pneumococcal disease following immunization with pneumococcal polysaccharide vaccine (PV)?
    Rodriguez-Barradas, MC
    Petersen, N
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1148 - 1148
  • [34] Comparison of immune response after vaccination with polysaccharide and glycoconjugate vaccines against encapsulated bacteria between HIV-infected and HIV-non-infected adults in the UK
    MacLennan, C. A.
    Birtwistle, J.
    Whitelegg, A.
    Faustini, S.
    Plant, T.
    Drayson, M.
    Manavi, K.
    Singo, M.
    Chigiga, J.
    Masuka, S.
    Hodson, J.
    HIV MEDICINE, 2016, 17 : 26 - 27
  • [35] The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: The effect of re-immunization with pneumococcal antigens
    Aaberge, IS
    Lovik, M
    APMIS, 1996, 104 (04) : 307 - 317
  • [36] The level of naturally occurring anti-αGal antibody predicts antibody response to polysaccharide vaccination in HIV-infected adults
    Jensen, Jens Magnus Bernth
    Sogaard, Ole Schmeltz
    Thiel, Steffen
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 93 (05)
  • [37] Race-related differences in functional antibody response to pneumococcal vaccination in HIV-infected individuals
    Happe, Myroslawa
    Samuvel, Devadoss J.
    Ohtola, Jennifer A.
    Korte, Jeff E.
    Westerink, M. A. Julie
    VACCINE, 2019, 37 (12) : 1622 - 1629
  • [38] PROTECTION AGAINST SALMONELLA-TYPHI INFECTION IN MICE AFTER IMMUNIZATION WITH OUTER-MEMBRANE PROTEINS ISOLATED FROM SALMONELLA-TYPHI 9,12,D,VI
    ISIBASI, A
    ORTIZ, V
    VARGAS, M
    PANIAGUA, J
    GONZALEZ, C
    MORENO, J
    KUMATE, J
    INFECTION AND IMMUNITY, 1988, 56 (11) : 2953 - 2959
  • [39] ANTIBODY-RESPONSE TO BOOSTER DOSES OF HEPATITIS-B VACCINE IN HIV-INFECTED CHILDREN
    CHOUDHURY, SA
    HODES, DS
    PETERS, VB
    PEDIATRIC RESEARCH, 1994, 35 (04) : A176 - A176
  • [40] Assessment of the antibody response in 110 healthy individuals who have been subject to Vi capsular polysaccharide vaccine
    Dizer, U
    Görenek, L
    Güner, Ö
    Pehlivan, T
    Özgüven, V
    Pahsa, A
    VACCINE, 2002, 20 (25-26) : 3052 - 3054